Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primary

Related articles

1. Comparison of Whole Genome Sequencing with Clinical Targeted Panel Sequencing of Metastatic Prostate Cancer: Insights from Real- World Data

   This article has 22 authors:

   1. Majd Al Assaad
   2. Sangmoon Lee
   3. Alissa Semaan
   4. David C. Wilkes
   5. Jyothi Manohar
   6. Gloria Cheang
   7. Oudai Hassan
   8. Georgi Lukose
   9. Christina Fedorov
   10. Jesus Delgado-de la Mora
   11. Eda Nur Kozan
   12. Daniela Guevara
   13. Olivier Elemento
   14. Clara Hwang
   15. Scott Tagawa
   16. Ana M. Molina
   17. David M. Nanus
   18. Jones T. Nauseef
   19. Cora N. Sternberg
   20. Erin Connolly-Strong
   21. James Solomon
   22. Juan Miguel Mosquera

2. A prospective national precision medicine trial comparing blood and tissue profiling in patients with Cancer of Unknown Primary (CUPCOMP)

   This article has 21 authors:

   1. Alicia-Marie Conway
   2. Matthew Robinson
   3. Matthew Concannon
   4. Sally Clive
   5. Tania Tillett
   6. Kai-Keen Shiu
   7. Louise Medley
   8. Sonali Dasgupta
   9. Eliyaz Ahmed
   10. Kelly Warrington
   11. Usman Mahmood
   12. Zoulikha Zair
   13. Tess Gillham
   14. Aaron Davis
   15. Julie-Anne Scott
   16. Alison Taylor
   17. Mark Stares
   18. Claire Mitchell
   19. Pedro Oliviera
   20. George J. Burghel
   21. Natalie Cook

3. A germline and somatic mutation sorting (GeMSort) algorithm for extracting presumed germline pathogenic variants in liquid genomic profiling: Insights from Database of Center for Cancer Genomics and Advanced Therapeutics (C-CAT)

   This article has 8 authors:

   1. Satoyo Oda
   2. Manami Matsukawa
   3. Chikako Tomozawa
   4. Noriko Tanabe
   5. Tomoko Watanabe
   6. Takafumi Koyama
   7. Teruhiko Yoshida
   8. Makoto Hirata